XML 38 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity (Tables)
 3 Months Ended
Dec. 31, 2017
Equity [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity under the Equity Plans for the three months ended December 31, 2017:


Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average
Remaining Contractual Life
(in years)
 
Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2017
326,798

 
$19.54
 
 
 
 
Granted
—

 
—

 
 
 
 
Exercised
(3,479
)
 
$4.50
 
 
 
$
13

Forfeited
(780
)
 
$4.22
 
 
 
 
Expired
(12,941
)
 
$27.59
 
 
 
 
Outstanding as of December 31, 2017
309,598

 
$19.41
 
1.70
 
$
143

Exercisable as of December 31, 2017
267,946

 
$21.71
 
0.76
 
$
67

Vested and expected to vest as of December 31, 2017
309,598

 
$19.41
 
1.70
 
$
143


(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the three months ended December 31, 2016, the intrinsic value of options exercised was $0.1 million.
Schedule of Restricted Stock Activity
The following table summarizes the activity related to RSUs and RSAs subject to time-based vesting requirements for the three months ended December 31, 2017:

Restricted Stock Activity
 
Restricted Stock Units
 
Restricted Stock Awards
 
Number of Shares
 
Weighted Average Grant Date Fair Value
 
Number of Shares
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2017
 
778,084

 
$5.91
 
8,154

 
$8.20
Granted
 
224,600

 
$6.73
 
—

 
$0.00
Vested
 
(40,095
)
 
$7.09
 
—

 
$0.00
Forfeited
 
(7,580
)
 
$4.02
 
—

 
$0.00
Non-vested as of December 31, 2017
 
955,009

 
$6.07
 
8,154

 
$8.20
Schedule of Performance Share Activity
The following table summarizes the activity related to PSUs and PRSAs for the three months ended December 31, 2017:

Performance Stock Activity
 
Performance Stock Units
 
Performance Stock Awards
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2017
 
328,708

 
$8.36
 
33,333

 
$12.25
Granted
 
240,164

 
$7.62
 
—

 
$0.00
Vested
 
(166,058
)
 
$6.86
 
—

 
$0.00
Non-vested as of December 31, 2017
 
402,814

 
$8.54
 
33,333

 
$12.25
Schedule of Stock-based Compensation Expense - By Award Type
The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type
For the three months ended December 31,
(in thousands)
2017
 
2016
Employee stock options
$
10

 
$
11

Restricted stock units and awards
451

 
354

Performance stock units and awards
289

 
268

Employee stock purchase plan
86

 
52

Outside director fees in common stock
79

 
78

Total stock-based compensation expense
$
915

 
$
763
Schedule of Stock-based Compensation Expense - By Expense Type
Stock-based Compensation Expense - by expense type
For the three months ended December 31,
(in thousands)
2017
 
2016
Cost of revenue
$
139

 
$
93

Selling, general, and administrative
638

 
570

Research and development
138

 
100

Total stock-based compensation expense
$
915

 
$
763
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net (loss) income per share:

Basic and Diluted Net (Loss) Income Per Share
 
For the three months ended December 31,
(in thousands, except per share)
 
2017
 
2016
Numerator:
 
 
 
 
   (Loss) income from continuing operations
 
$
(82
)
 
$
1,766

   Loss from discontinued operations
 
—

 
(9
)
Undistributed earnings allocated to common shareholders for basic and diluted net income per share
 
(82
)
 
1,757

Denominator:
 
 
 
 
Denominator for basic net income per share - weighted average shares outstanding
 
27,032

 
26,279

Dilutive options outstanding, unvested stock units, unvested stock awards and ESPP
 
—

 
760

Denominator for diluted net income per share - adjusted weighted average shares outstanding
 
27,032

 
27,039

 
 
 
 
 
Net (loss) income per basic share:
 
 
 
 
   Continuing operations
 
$
(0.00
)
 
$
0.07

   Discontinued operations
 
0.00

 
(0.00
)
Net (loss) income per basic share
 
$
(0.00
)
 
$
0.07

 
 
 
 
 
Net (loss) income per diluted share:
 
 
 
 
   Continuing operations
 
$
(0.00
)
 
$
0.07

   Discontinued operations
 
0.00

 
0.00

Net (loss) income per diluted share
 
$
(0.00
)
 
$
0.07

Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation
 
911

 
529

 
 
 
 
 
Average market price of common stock
 
$
7.50

 
$
6.88
Schedule of Common Stock Reserved for Future Issuances
As of December 31, 2017, we had common stock reserved for the following future issuances:
Future Issuances
Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options
309,598

Unvested restricted stock units
955,009

Unvested performance stock units
805,628

Purchases under the employee stock purchase plan
911,071

Issuance of stock-based awards under the Equity Plans
1,882,779

Purchases under the officer and director share purchase plan
88,741

Total reserved
4,952,826